Medication info
Tenelo M Extended Release Tablet 10/750 mg

Tenelo M Extended Release Tablet 10/750 mg

Prescription medicationTabletOral
Ingredient · strength
Teneligliptin Hydrochloride Hydrate›13mg / 1 tabletMetformin Hydrochloride›750mg / 1 tablet
Manufacturer / importer
Hallym Pharmaceutical Co., Ltd.
Appearance
Yellow oval-shaped extended release film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202201424 · Approved 2022.04.04 · Insurance code 645306750

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, and the dose should be titrated gradually to reduce gastrointestinal adverse reactions associated with metformin. Take 1 tablet of this medicine 20/1000mg extended-release tablet once daily. Patients taking this medicine 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current metformin dose. For patients switching from combination therapy with teneligliptin and metformin to this medicine, treatment may be initiated at the current doses of teneligliptin and metformin. When switching from immediate-release to extended-release metformin, blood glucose control should be closely monitored, and the dose should be adjusted as appropriate. When coadministered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from other glucose-lowering medicines. Since this may cause changes in blood glucose control, any change in the treatment of patients with type 2 diabetes should be made under close monitoring. To maintain its extended-release properties, swallow this medicine whole without splitting, crushing, grinding, or chewing it.

Ingredients

Manufacturer
Hallym Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes mellitus

View approved original text

This medication helps control blood sugar levels in patients with type 2 diabetes by using Teneligliptin and Metformin together. It enhances blood sugar control effects when used alongside dietary and exercise therapy. Therefore, this medication is used to improve blood sugar management.

How to take

Adult dose

The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, and the dose should be titrated gradually to reduce gastrointestinal adverse reactions associated with metformin. Take 1 tablet of this medicine 20/1000mg extended-release tablet once daily. Patients taking this medicine 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current metformin dose. For patients switching from combination therapy with teneligliptin and metformin to this medicine, treatment may be initiated at the current doses of teneligliptin and metformin. When switching from immediate-release to extended-release metformin, blood glucose control should be closely monitored, and the dose should be adjusted as appropriate. When coadministered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from other glucose-lowering medicines. Since this may cause changes in blood glucose control, any change in the treatment of patients with type 2 diabetes should be made under close monitoring. To maintain its extended-release properties, swallow this medicine whole without splitting, crushing, grinding, or chewing it.

Precautions

This medication is used to assist with blood sugar control, particularly in patients with diabetes. It contains Metformin, which may be dangerous for patients with impaired kidney function; thus, patients with reduced kidney function should not use it. Additionally, this medication should not be administered to patients with heart failure, acute myocardial infarction, or severe infections. This medication can cause a rare but serious side effect known as lactic acidosis, a condition where lactic acid accumulates in the body and can be life-threatening. Patients at risk of lactic acidosis, such as those with poor liver function or severe hypoxia, should exercise particular caution. Also, taking this medication in conjunction with insulin or sulfonylureas may increase the risk of hypoglycemia, so blood sugar levels must be closely monitored. It is advisable for women who are pregnant, potentially pregnant, or breastfeeding to avoid this medication. During treatment, it is important to avoid alcohol consumption, and if sudden dehydration, severe vomiting, or diarrhea occurs, medical consultation should be sought immediately. If surgery is planned or iodine contrast studies are to be conducted, the medication needs to be temporarily discontinued for a period, and kidney function must be verified before resuming use. Elderly patients or those with compromised kidney function should have regular kidney function tests, and dose adjustments may be necessary. Patients should be well-informed about symptoms of hypoglycemia and initial signs of lactic acidosis, and should seek medical attention immediately if symptoms arise. Some patients may experience side effects such as dyspepsia, constipation, dizziness, skin rashes; any unusual symptoms should be reported to healthcare professionals. There could also be potential interactions with other medications, so it is essential that patients inform their doctor or pharmacist of any other medications they are taking.

Side effects

  • Severe lactic acidosis
  • severe hypoglycemia
  • hypoglycemia
  • constipation
  • intestinal obstruction
  • liver dysfunction
  • interstitial pneumonia
  • pemphigus-like dermatitis
  • acute pancreatitis
  • dizziness
Show 197 more
  • abdominal distension
  • abdominal discomfort
  • nausea
  • abdominal pain
  • bloating
  • stomatitis
  • gastric polyps
  • colon polyps
  • duodenal ulcers
  • gastroesophageal reflux disease
  • diarrhea
  • appetite loss
  • elevated amylase
  • elevated lipase
  • increased AST (GOT)
  • increased ALT (GPT)
  • increased GGT
  • increased ALP
  • proteinuria
  • ketonuria
  • potential hematuria
  • eczema
  • rash
  • itching
  • allergic dermatitis
  • arthralgia
  • elevated CK (CPK)
  • increased serum potassium concentration
  • fatigue
  • allergic rhinitis
  • increased serum uric acid
  • peripheral edema
  • shingles
  • limb pain
  • epigastric pain
  • gastritis
  • upper respiratory infection
  • tremor
  • headache
  • weakness
  • hunger
  • fatigue
  • facial edema
  • dyspepsia
  • nausea
  • viral upper respiratory infection
  • rhinitis
  • sweating
  • diabetic retinopathy
  • decreased vision
  • cough
  • pulmonary congestion
  • dyspnea
  • drug overdose
  • benign prostatic hyperplasia
  • cerebral infarction
  • hyperglycemia
  • liver biopsy
  • decreased neutrophil count
  • abnormal blood sugar
  • increased blood sugar
  • increased blood pressure
  • hepatic coma
  • lumbar spinal canal stenosis
  • intervertebral disc herniation
  • intervertebral disc disorders
  • spinal ligament ossification
  • foraminal stenosis
  • rotator cuff syndrome
  • bladder mass
  • ureterolithiasis
  • urinary stones
  • coronary artery disease
  • unstable angina
  • gastroesophageal reflux disease
  • gastric polyps
  • gastritis
  • biliary obstruction
  • chronic cholecystitis
  • soft tissue infection
  • pneumonia
  • cataract
  • depression
  • iliac artery stenosis
  • vertigo
  • benign prostatic hyperplasia
  • knee surgery
  • dizziness
  • diabetic neuropathy
  • headache
  • sensory abnormalities
  • arthralgia
  • nasopharyngitis
  • gastritis
  • dyspepsia
  • hypercholesterolemia
  • hyperglycemia
  • hyperlipidemia
  • hypertension
  • cough
  • insomnia
  • urticaria
  • hepatic coma
  • sensory disturbances
  • sensory loss
  • tension headache
  • peripheral neuropathy
  • facial paralysis
  • sciatica
  • orthostatic dizziness
  • muscle weakness
  • low back pain
  • limb pain
  • lumbar spinal canal stenosis
  • tendinitis
  • cervical pain
  • bone pain
  • osteoarthritis
  • osteoporosis
  • muscle cramps
  • foot deformities
  • hypertrophic osteoarthropathy
  • bursitis
  • spinal osteoarthritis
  • intervertebral disc herniation
  • intervertebral disc disorders
  • spinal ligament ossification
  • foraminal stenosis
  • postmenopausal osteoporosis
  • rotator cuff syndrome
  • shingles
  • upper respiratory infection
  • gastroenteritis
  • pneumonia
  • H1N1 influenza
  • bronchitis
  • chronic sinusitis
  • folliculitis
  • cystitis
  • soft tissue infection
  • urinary tract infection
  • pharyngitis
  • streptococcal infection
  • athlete's foot
  • subcutaneous abscess
  • Helicobacter gastritis
  • vomiting
  • chronic gastritis
  • epigastric pain
  • stomatitis
  • esophagitis
  • gastrointestinal motility disorders
  • decreased gastrointestinal motility
  • enteritis
  • toothache
  • anal rectal discomfort
  • acquired mixed hyperlipidemia
  • hypertriglyceridemia
  • vitamin D deficiency
  • abnormal weight gain
  • essential hypertension
  • orthostatic hypotension
  • white coat hypertension
  • bleeding
  • chest discomfort
  • peripheral edema
  • fever
  • chills
  • generalized edema
  • injection site inflammation
  • fatigue
  • chest pain
  • dysuria
  • kidney cyst
  • nocturia
  • ovarian cyst
  • vulvar pruritus
  • menopausal symptoms
  • toxic hepatitis
  • non-alcoholic fatty liver disease
  • alcoholic liver disease
  • eyelid injury
  • ligament sprain
  • lip injury
  • contusion
  • pressure ulcer
  • glaucoma
  • blurred vision
  • age-related macular degeneration
  • hyperthyroidism
  • hyperparathyroidism
  • coronary artery disease
  • unstable angina
  • angina
  • otalgia
  • iron deficiency anemia
  • food allergy

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air exposure, preferably at room temperature between 1 and 30 degrees Celsius. Storing the medication this way helps maintain its effectiveness and prevents deterioration.

Appearance and packaging

Appearance

Yellow oval-shaped extended release film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.